411 related articles for article (PubMed ID: 31683679)
1. Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats.
Deng Y; Pan M; Nie H; Zheng C; Tang K; Zhang Y; Yang Q
Molecules; 2019 Oct; 24(21):. PubMed ID: 31683679
[TBL] [Abstract][Full Text] [Related]
2. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
[TBL] [Abstract][Full Text] [Related]
3. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
4. p38 MAPK signal pathway involved in anti-inflammatory effect of Chaihu-Shugan-San and Shen-ling-bai-zhu-San on hepatocyte in non-alcoholic steatohepatitis rats.
Yang Q; Xu Y; Feng G; Hu C; Zhang Y; Cheng S; Wang Y; Gong X
Afr J Tradit Complement Altern Med; 2014; 11(1):213-21. PubMed ID: 24653580
[TBL] [Abstract][Full Text] [Related]
5. Exploration the mechanism of Shenling Baizhu San in the treatment of chronic obstructive pulmonary disease based on UPLC-Q-TOF-MS/MS, network pharmacology and in vitro experimental verification.
Gao Z; Wang J; Lu G; Wu Q; Wang S; Wu X; Ou C; Wu Z; Yu H; Wang Y
J Ethnopharmacol; 2024 Apr; 324():117728. PubMed ID: 38216101
[TBL] [Abstract][Full Text] [Related]
6. Chinese Herbal Medicine Formula Shenling Baizhu San Ameliorates High-Fat Diet-Induced NAFLD in Rats by Modulating Hepatic MicroRNA Expression Profiles.
Pan M; Deng Y; Zheng C; Nie H; Tang K; Zhang Y; Yang Q
Evid Based Complement Alternat Med; 2019; 2019():8479680. PubMed ID: 31915454
[TBL] [Abstract][Full Text] [Related]
7. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
[TBL] [Abstract][Full Text] [Related]
8. Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease.
Zhou M; Liu X; Wu Y; Xiang Q; Yu R
J Ethnopharmacol; 2024 Jul; 329():118160. PubMed ID: 38588985
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c.
Tang K; Deng Y; Zheng C; Nie H; Pan M; Chen R; Xie J; Yang Q; Zhang Y
Oxid Med Cell Longev; 2020; 2020():9701285. PubMed ID: 33062150
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of Hua Tan Qu Shi decoction against liver injury in rats with nonalcoholic fatty liver disease.
Zhao SP; Wu ZS; Chen Y; Liang X; Bao L; Li P; Sun RR; Wu YL; Li LR; Wang Q
Biomed Pharmacother; 2017 Jul; 91():181-190. PubMed ID: 28458156
[TBL] [Abstract][Full Text] [Related]
11. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
[TBL] [Abstract][Full Text] [Related]
13. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease.
Pan MX; Zheng CY; Deng YJ; Tang KR; Nie H; Xie JQ; Liu DD; Tu GF; Yang QH; Zhang YP
J Integr Med; 2021 Sep; 19(5):428-438. PubMed ID: 34426178
[TBL] [Abstract][Full Text] [Related]
14. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
[TBL] [Abstract][Full Text] [Related]
15. A review of pharmacological and clinical studies on the application of Shenling Baizhu San in treatment of Ulcerative colitis.
Ma Q; Ouyang Y; Meng F; Noolvi MN; Avvaru SP; More UA; Aminabhavi TM; Du M; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
J Ethnopharmacol; 2019 Nov; 244():112105. PubMed ID: 31344480
[TBL] [Abstract][Full Text] [Related]
16. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
Jiang Y; Chen L; Wang H; Narisi B; Chen B
J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats.
Ding S; Jiang J; Zhang G; Bu Y; Zhang G; Zhao X
PLoS One; 2017; 12(8):e0183541. PubMed ID: 28817690
[TBL] [Abstract][Full Text] [Related]
18. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.
Yao X; Xia F; Tang W; Xiao C; Yang M; Zhou B
J Ethnopharmacol; 2018 Feb; 212():208-215. PubMed ID: 29031784
[TBL] [Abstract][Full Text] [Related]
19. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
Chen M; Xing J; Pan D; Peng X; Gao P
Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
[TBL] [Abstract][Full Text] [Related]
20. A Novel Role of SIRT1/ FGF-21 in Taurine Protection Against Cafeteria Diet-Induced Steatohepatitis in Rats.
Abd Elwahab AH; Ramadan BK; Schaalan MF; Tolba AM
Cell Physiol Biochem; 2017; 43(2):644-659. PubMed ID: 28942443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
